Ph.D. students
Centro di Ricerca Interdisciplinare Health Science
Riccardo Gurrieri
Bio
Education
- 2019–2022: Bachelor’s Degree in Clinical and Health Psychology, University of Pisa (cum laude; thesis awarded publication distinction)
- 2022–2024: Master’s Degree in Clinical and Health Psychology, University of Pisa (cum laude; thesis awarded publication distinction)
- 2022–2024: Master’s Degree in Human Nutrition Sciences, San Raffaele University, Rome (cum laude)
- 2025–present: Postgraduate School of Specialization in Cognitive Behavioral Psychotherapy, Miller Institute, Florence
- 2025–present: PhD Programme in Translational Medicine, Sant’Anna School of Advanced Studies
Work Experience
- 09/2023–07/2024: Volunteer Trainee, Psychiatry Unit, Azienda Ospedaliero-Universitaria Pisana (AOUP), Pisa
- 01/2024–06/2024: Tutor for Students with Specific Learning Disorders, University of Pisa
- 09/2024–12/2024: Research Fellowship, Neonatology Unit, AOUP, Pisa
- 11/2024–05/2025: Postgraduate Practical Internship, PAIM Cooperative, Pisa
- 04/2025–06/2025: External Lecturer in Psychology, Galilei-Pacinotti High School, Pisa
- 04/2025–06/2025: External Lecturer in Psychology, F. Russoli Art High School, Pisa
- 09/2025: External Lecturer in Science (Laboratory Activities), “Liana Stretta Tongiorgi” Institute, Pisa
- 2025–present: Field Editor, CNS Spectrums (Cambridge University Press)
- 2025–present: Field Editor, Clinical Neuropsychiatry
Ricerca
- Investigation of the microbiota–gut–brain axis as a modulator of resilience and vulnerability to psychiatric disorders
Pubblicazioni
Marazziti, D., Gambini, M., Russomanno, G., Carbone, M. G., Mucci, F., & Gurrieri, R. (2026). Disorders of Mood and Affect. Psychiatric Clinics.
Marazziti, D., Gambini, M., Pescini, E., & Gurrieri, R. (2026). Time Perception in Psychiatric Disorders. Psychiatric Clinics.
Marazziti, D., Russomanno, G., Gambini, M., Digiuseppe, F. R., Fazio, E., & Gurrieri, R. (2026). Sensory Deprivation and the Brain: Neurobiological Mechanisms, Psychological Effects, and Clinical Implications. Brain Sciences, 16(2), 122.
Gurrieri, R., Gambini, M., Russomanno, G., Mucci, F., Carbone, M. G., Sità, G., ... & Marazziti, D. (2025). Memory in Psychiatric Disorders: A Review. Life, 15(12), 1926.
Gurrieri, R., Gambini, M., Pescini, E., Mastrogiacomo, D., Russomanno, G., & Marazziti, D. (2025). Memory functions in obsessive–compulsive disorder. Brain Sciences, 15(5), 492.
Gurrieri, R., Russomanno, G., Gambini, M., Pescini, E., Sità, G., & Marazziti, D. (2025). The Duration of Untreated Illness in Major Depressive Disorder: Clinical Relevance, Predictors, and Strategies for Early Intervention. Psychiatry Research Communications, 100231.
Weiss, F., Magnesa, A., Gambini, M., Gurrieri, R., Annuzzi, E., Elefante, C., ... & Marazziti, D. (2025). Psychedelic-induced neural plasticity: A comprehensive review and a discussion of clinical implications. Brain Sciences, 15(2), 117.
Marazziti, D., Gurrieri, R., Gambini, M., Russomanno, G., Palagini, L., & Mucci, F. (2025). Innovative treatment approaches for paediatric obsessive-compulsive disorder. Expert Opinion on Pharmacotherapy, 26(17), 1763-1784.
Marazziti, D., Palermo, S., Arone, A., Carbone, M. G., Massa, L., Crowther, L. F., ... & Dell’Osso, L. (2025). The role of previous streptococcal infections in adult patients with obsessive-compulsive disorder: a research study. CNS spectrums, 30(1), e38.
Marazziti, D., Weiss, F., Gurrieri, R., Russomanno, G., Gambini, M., Magnesa, A., ... & Perugi, G. (2025). Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective. Expert Review of Neurotherapeutics, 25(2), 143-156.
Marazziti, D. T., Caruso, V., Cappellato, G., Chiarantini, I., Gurrieri, R., Perrone, P., ... & Perugi, G. (2025). The emerging role of N-acetylcysteine in psychiatry: a narrative review of available data. Current Medicinal Chemistry.
Palagini, L., Alfi, G., Gurrieri, R., Annuzzi, E., Caruso, V., Gambini, M., ... & Gemignani, A. (2024). Early experience with the new DORA daridorexant in patients with insomnia disorder and comorbid mental disturbances: Results of a naturalistic study with 3 months follow‐up. Journal of Sleep Research, 33(6), e14196.
Palagini, L., Geoffroy, P. A., Alfi, G., Annuzzi, E., Gurrieri, R., Caruso, V., ... & Riemann, D. (2024). Insomnia and the orexinergic pathway in the link with psychopathology: effects of DORAs in insomnia comorbid with mental disturbances. Current Sleep Medicine Reports, 10(2), 119-131.
Marazziti, D., Massa, L., Carbone, M. G., Palermo, S., Arone, A., D’Angelo, G., ... & Dell’Osso, L. (2024). Silent infections are not so silent: the emerging role of combined infections, inflammation, and vitamin levels in OCD. Clinical Neuropsychiatry, 21(1), 7.